Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $4.77 Million - $8.28 Million
213,968 New
213,968 $6.57 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $217,751 - $329,110
6,367 Added 7.71%
88,957 $3.04 Million
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $219,598 - $471,463
9,490 Added 12.98%
82,590 $2.87 Million
Q1 2022

May 11, 2022

SELL
$27.77 - $64.4 $25,437 - $58,990
-916 Reduced 1.24%
73,100 $3.22 Million
Q4 2021

Feb 11, 2022

SELL
$54.9 - $105.21 $5 Million - $9.57 Million
-90,998 Reduced 55.15%
74,016 $4.65 Million
Q3 2021

Nov 12, 2021

SELL
$105.0 - $178.37 $1.65 Million - $2.81 Million
-15,744 Reduced 8.71%
165,014 $17.4 Million
Q2 2021

Aug 11, 2021

BUY
$125.11 - $180.0 $2.76 Million - $3.97 Million
22,068 Added 13.91%
180,758 $32 Million
Q1 2021

May 13, 2021

BUY
$126.27 - $191.71 $3.16 Million - $4.8 Million
25,012 Added 18.71%
158,690 $21.2 Million
Q4 2020

Feb 09, 2021

BUY
$81.94 - $135.34 $1.14 Million - $1.88 Million
13,927 Added 11.63%
133,678 $18.1 Million
Q3 2020

Nov 12, 2020

BUY
$73.3 - $89.48 $3.72 Million - $4.54 Million
50,745 Added 73.54%
119,751 $9.96 Million
Q2 2020

Aug 12, 2020

BUY
$48.82 - $82.53 $1.15 Million - $1.94 Million
23,480 Added 51.57%
69,006 $5.67 Million
Q1 2020

May 06, 2020

BUY
$39.1 - $62.9 $1.55 Million - $2.5 Million
39,752 Added 688.47%
45,526 $2.34 Million
Q4 2019

Feb 14, 2020

BUY
$29.79 - $43.06 $172,007 - $248,628
5,774 New
5,774 $240,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.